UC launches 'REVIVE' clinical trial to test treatment for abdominal injury
Researchers at the University of Cincinnati are launching a clinical study for ResQFoam™, a new device for the treatment of life-threatening internal bleeding in the abdomen. UC Medical Center is one of a handful of Level I Trauma Centers in the United States selected to participate in the multicenter study.
Related Stories
UC Foundation celebrates 2026 philanthropy winners
October 23, 2026
The University of Cincinnati Foundation recognized its Outstanding Philanthropic Volunteer Award honorees at the George Rieveschl Recognition Dinner on October 22, 2026.
AI breast cancer survival model from Cancer Center could improve accuracy and personalize care
October 23, 2026
UC Cancer Center researchers, including lead author Wedad Alatebi, developed a deep learning survival model for breast cancer that combines detailed clinical and genetic information, potentially offering physicians a more accurate tool to guide treatment decisions.
UC expert explains potential impact of Pennsylvania’s new vape product law
October 22, 2026
UC professor Ashley Merianos speaks to the Pittsburgh Post-Gazette about Pennsylvania’s new vape law, youth vaping prevention, enforcement challenges and possible unintended consequences.